Skip to main content
SpringerLink
Log in

Vorgeburtliche Schädigungen

  • Chapter
Therapie der Krankheiten im Kindes- und Jugendalter

  • 158 Accesses

Auszug

Das ungeborene Kind ist potenziell gefährdet durch eine Vielzahl möglicher mütterlicher Erkrankungen, durch bestimmte mütterliche Immunreaktionen, durch Medikamente oder auch durch eine Abhängigkeit von Suchtmitteln. Die Folgezustände beim Neugeborenen, insbesondere z.B. das neonatale Drogenentzugssyndrom, werden zu selten diagnostiziert, da u.a. die Kenntnis dieser verschiedenartigsten fetalen und neonatalen Erkrankungen oft unzureichend ist. Dies kann zum Nachteil des Kindes werden, da für viele solcher spezieller Erkrankungen des Neugeborenen wirksame Behandlungsmethoden zur Verfügung stehen. Das folgende Kapitel behandelt einige der häufiger zu beobachtenden Erkankungen aus diesem Problemkreis. Es ist keine erschöpfende Darstellung, sondern eine Einstiegshilfe.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Acker DB, Sachs BP, Friedman EA (1985) Risk factors for shoulder dystocia. Obstet Gynecol 66: 762–768

    PubMed  CAS  Google Scholar 

  • Andrew M, Kelton J (1984) Neonatal thrombocytopenia. Clin Perinatol 11: 359–391

    PubMed  CAS  Google Scholar 

  • AWMF Leitlinie (2003) Betreuung von Neugeborenen diabetischer Mütter. Frauenarzt 44: 439–441

    Google Scholar 

  • Baar AL van, Fleury P, Ultee CA (1989) Behaviour in the first year after drug dependent pregnancy. Arch Dis Child 64: 241–245

    PubMed  Google Scholar 

  • Bavoux F, Fournier-Perkilou AI, Wood C, Francoual C, Boccara JF (1994) Neonatal fibrinogen depletion cause by sodium valproate. Ann Pharmacother 28: 1307

    PubMed  CAS  Google Scholar 

  • Bleyer WA, Marshall RE (1972) Barbiturate withdrawal syndrome in a passively addicted infant. JAMA 221: 185–186

    Article  PubMed  CAS  Google Scholar 

  • Buyon JP, Clany RM (2003) Maternal autoantibodies and congenital heart block: Mediators, markers, and therapeutic approach. Semin Arthritis Rheuma 33: 1840–154

    Google Scholar 

  • Chasnoff IJ, Burns WJ (1984) The Moro reaction: a scoring system for neonatal narcotic withdrawal. Dev Med Child Neurol 26: 484–489

    Article  PubMed  CAS  Google Scholar 

  • Chasnoff IJ, Bussey ME, Savich R et al. (1986) Perinatal cerebral infarction and maternal cocaine use. J Pediatr 108: 456–459

    Article  PubMed  CAS  Google Scholar 

  • Clarren SK, Alvord ECJ, Sumi SM (1978) Brain malformations related to prenatal exposure to ethanol. J Pediatr 92: 64–67

    Article  PubMed  CAS  Google Scholar 

  • Coles CD, Smith IE, Fernhoff PM et al. (1984) Neonatal ethanol withdrawal: characteristics in clinically normal, nondysmorphic neonates. J Pediatr 105: 445–451

    Article  PubMed  CAS  Google Scholar 

  • Conway DL, Langer O (1998) Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 178: 922–925

    Article  PubMed  CAS  Google Scholar 

  • Cornelissen M, Steegers-Theunissen R, Kollée L, Eskes T, Motohara K, Monnens L (1993) Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 168: 884–888

    PubMed  CAS  Google Scholar 

  • Cowe L, Lloyd DJ, Dawling S (1982) Neonatal convulsions caused by withdrawal from maternal clomipramine. BMJ 284: 1837–1838

    PubMed  CAS  Google Scholar 

  • Danziger Y, Pertzelan A, Mimouni M (1987) Transient congenital hypothyroidism after topical iodine in pregnancy and lactation. Arch Dis Child 62: 295–296

    PubMed  CAS  Google Scholar 

  • Davidson DC, Gregg JE, Weindling AM (1993) Methadone therapy. Lancet 341: 1277–1278

    Google Scholar 

  • Desmond MM, Schwanecke RP, Wilson GS (1972) Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr 80: 190–197

    Article  PubMed  CAS  Google Scholar 

  • DGKJ (1995) Vitamin K Prophylaxe für Neugeborene. Monatsschr Kinderheilkd 143: 93

    Google Scholar 

  • Doberczak TM, Kandall SR, Friedmann P (1993) Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 81: 936–940

    PubMed  CAS  Google Scholar 

  • Doberczak TM, Kandall SR, Wilets I (1991) Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 118: 933–937

    Article  PubMed  CAS  Google Scholar 

  • Ebbesen F, Joergensen A, Hoseth E, Kaad PH, Moeller M, Holsteen V, Rix M (2000) Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed 83: F124–F129

    Article  PubMed  CAS  Google Scholar 

  • Finnegan L (1991) Perinatal substance abuse: comments and perspectives. Semin Perinatol 15: 331–339

    PubMed  CAS  Google Scholar 

  • Finnegan LP, Connaughton JFJ, Kron RE, Emich JP (1975) Neonatal abstinence syndrome: assessment and management. Addict Dis 2: 141–158

    PubMed  CAS  Google Scholar 

  • Friedler G, Cochin J (1972) Growth retardation in offspring of female rats treated with morphine prior to conception. Science 175: 654–656

    Article  PubMed  CAS  Google Scholar 

  • Garcia-Algar O, Puig C, Mendez C, Vall O, Pacifici R, Pichini S (2001) Neonatal nicotine withdrawal syndrome. J Epidemiol Community Health 55: 687–688

    Article  PubMed  CAS  Google Scholar 

  • Green M, Suffet F (1981) The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse 8: 203–213

    Article  PubMed  CAS  Google Scholar 

  • Haustein K-O (2000) Rauchen, Nikotin und Schwangerschaft. Geburtsh Frauenheilk 60: 11–19

    Article  Google Scholar 

  • Herzlinger RA, Kandall SR, Vaughan HG (1977) Neonatal seizures associated with narcotic withdrawal. J Pediatr 91: 638–641

    Article  PubMed  CAS  Google Scholar 

  • Hey E (1999) Effect of maternal anticonvulsant treatment on neonatal blood coagulation. Arch Dis Child Fetal Neonatal Ed 81: F208–F210

    PubMed  CAS  Google Scholar 

  • Howe AM, Oakes DJ, Woodman PD, Webster WS (1999) Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Epilepsia 40: 980–984

    Article  PubMed  CAS  Google Scholar 

  • Hoyme HE, Jones KL, Dixon SD et al. (1990) Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85: 743–747

    PubMed  CAS  Google Scholar 

  • Ito S (2000) Drug therapy for breast-feeding women. N Engl J Med 343: 118–126

    Article  PubMed  CAS  Google Scholar 

  • Jäger-Roman E, Deich A, Jakob S (1986) Fetal growth, major malformations, and minor abnormalities in infants born to women receiving valproic acid. J Pediatr 108: 997–1004

    Article  PubMed  Google Scholar 

  • Johnson JA, Ryan G, al-Musa A, Farkas S, Blanchette VS (1997) Prenatal diagnosis and management of neonatal alloimmune thrombocytopenia. Semin Perinatol 21: 45–52

    Article  PubMed  CAS  Google Scholar 

  • Jones KL (1975) Aberrant neuronal migration in the fetal alcohol syndrome. Birth Def 7: 131–132.

    Google Scholar 

  • Kaaja E, Kaaja R, Matila R, Hiilesmaa V (2002) Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58: 549–553

    PubMed  CAS  Google Scholar 

  • Kandall SR, Albin S, Lowinson J, Berle B, Eidelman AI, Gartner LM (1976) Differential effects of maternal heroin and metadone use on birthweight. Pediatrics 58: 681–685

    PubMed  CAS  Google Scholar 

  • Kandall SR, Doberczak TM, Mauer KR, Strashun RH, Korts DC (1983) Opiate v CNS depressant therapy in neonatal drug abstinence syndrome. Am J Dis Child 137: 378–382

    PubMed  CAS  Google Scholar 

  • Kandall SR, Gaines J, Habel L et al. (1993) Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr 123: 120–126

    Article  PubMed  CAS  Google Scholar 

  • Khan K, Chang J (1997) Neonatal abstinence syndrome due to codeine. Arch Dis Child 76: F59–F60

    CAS  Google Scholar 

  • Koch S, Jäger-Roman E, Lösche G (1996) Antiepileptic drug treatment in pregnant epileptic women: pharmacokinetics and drug side effects in the neonate and neurologic outcome at age 6. Acta Paediatr 84: 739–746

    Google Scholar 

  • Lee LA (2001) Neonatal lupus: clinical features, therapy, and pathogenesis. Curr Rheumatol Rep 3: 391–395

    Article  PubMed  CAS  Google Scholar 

  • Letsky EA, Greaves M (1996) Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Br J Haematol 95: 21–26

    PubMed  CAS  Google Scholar 

  • Levy M, Sino M (1993) Neonatal withdrawal syndrome: associated drugs and pharmacologic management. Pharmacotherapy 13: 202–211

    PubMed  CAS  Google Scholar 

  • Lifschitz MH, Wilson GS, Smith EO (1985) Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 75: 269–274

    PubMed  CAS  Google Scholar 

  • Lipsitz PJ (1975) A proposed narcotic withdrawal score for use with newborn infants. Clin Pediatr 14: 592–594

    Article  CAS  Google Scholar 

  • Longo LD (1977) The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am J Obstet Gynecol 129: 69–103

    PubMed  CAS  Google Scholar 

  • Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R (1977) Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 127: 199–201

    PubMed  CAS  Google Scholar 

  • Mangurten HH (1980) Neonatal codeine withdrawal in infants of non-addicted mothers. Pediatrics 65: 159–160

    PubMed  CAS  Google Scholar 

  • Martinez A, Partridge JC, Bean X, Taeusch HW (1998) Perinatal substance abuse. In: Taeusch HW, Ballard RA (eds) Avery’s diseases of the newborn. WB Saunders, Philadelphia, pp 103–118

    Google Scholar 

  • McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH (1999) Congenital anomalies after prenatal ecstasy exposure. Lancet 354: 1441–1442

    Article  PubMed  CAS  Google Scholar 

  • McKenzie JM, Zakarija M (1978) Pathogenesis of neonatal Graves’ disease. J Endocrinol Invest 2: 183–187

    Google Scholar 

  • Mestman JH (1998) Parathyroid disorders of pregnancy. Semin Perinatol 22: 485–96

    Article  PubMed  CAS  Google Scholar 

  • Molad Y (2006) Systemic lupus erythematosus and pregnancy. Curr Opin Obstet Gynecol 18: 613–617

    Article  PubMed  Google Scholar 

  • Obrocki J, Andresen B, Schmoldt A, Thomasius A (2001) Anhaltende neurotoxische Schäden durch Ecstasy. Dt Aerztebl 98: A3132–3138

    Google Scholar 

  • Omtzigt JG, Los FJ, Grobbee DE (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42: 119–125

    PubMed  CAS  Google Scholar 

  • Oro AS, Dixon SD (1987) Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 111: 571–578

    Article  PubMed  CAS  Google Scholar 

  • Ostrea EM Jr (1982) Neonatal withdrawal from intrauterine exposure to butalbital. Am J Obstet Gynecol 143: 597–598

    PubMed  Google Scholar 

  • Ostrea EM Jr, Lucena JL, Silvestre MA (1994) The infant of the drug-dependent mother. In: Avery GB, Fletcher MA, MacDonald MG (eds) Neonatology: pathophysiology and management of the newborn. JB Lippincott, Philadelphia, pp 1300–1333

    Google Scholar 

  • Pacifico P, Nardelli E, Pantarotto MF (1989) Neonatal heroin withdrawal syndrome: evaluation of different pharmacological treatments. Pharmacol Res 21 (suppl): 63–64

    Article  PubMed  Google Scholar 

  • Pierog S, Chandavasu O, Wexler I (1977) Withdrawal symptoms in infants with the fetal alcohol syndrome. J Pediatr 90: 630–633

    Article  PubMed  CAS  Google Scholar 

  • Renzulli P, Tuchschmid P, Eich G, Fanconi S, Schwöbel MG (1998) Early vitamin K deficiency bleeding after maternal phenobarbital intake: management of massive intracranial haemorrhage by minimal surgical intervention. Eur J Pediatr 157: 663–665

    Article  PubMed  CAS  Google Scholar 

  • Rosen TS, Pippenger CE (1976) Pharmacologic observations on the neonatal withdrawal syndrome. J Pediatr 88: 1044–1048

    Article  PubMed  CAS  Google Scholar 

  • Roti E (1988) Regulation of thyroid-stimulating hormone (TSH) secretion in the fetus and neonate. J Endocrinol Invest 11: 145–150

    PubMed  CAS  Google Scholar 

  • Rouse DJ, Owen J, Godenberg RL (1996) The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA 276: 1480–1486

    Article  PubMed  CAS  Google Scholar 

  • Schellscheidt J, Oyen N, Jorch G (1997) Interactions between maternal smoking and other prenatal risk factors for sudden infant death syndrome (SIDS). Acta Paediatr 86: 857–863

    Article  PubMed  CAS  Google Scholar 

  • Schydlower M, Committee on substance abuse (1993) Fetal alcohol syndrome and fetal alcohol effects. Pediatrics 91: 1004–1006

    Google Scholar 

  • Shangold MM, Dor N, Welt SI, Fleischman AR, Crenshaw MC Jr (1982) Hyperparathyroidism and pregnancy: a review. Obstet Gynecol Surv 37: 217–228

    Article  PubMed  CAS  Google Scholar 

  • Shinohara K, Miyagawa S, Fujita T et al. (1999) Neonatal lupus erythematosus: results of a maternal corticosteroid therapy. Obstet Gynecol 93: 952–957

    Article  PubMed  CAS  Google Scholar 

  • Silverman ED, Laxer RM (1997) Neonatal lupus erythematosus. Rheum Dis Clin North Am 23: 599–618

    Article  PubMed  CAS  Google Scholar 

  • Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D, Lindow SW (2001) Neonatal outcome following maternal opiate use in late pregnancy. Int J Gynaecol Obstet 74: 241–246

    Article  PubMed  CAS  Google Scholar 

  • Slotkin TA, Lappi SE, McCook EC, Lorber BA, Seidler FJ (1995) Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull 38: 69–75

    Article  PubMed  CAS  Google Scholar 

  • Steward DJ, Inaba T, Lucassen M et al. (1979) Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 25: 464–468

    Google Scholar 

  • Theis JG, Selby P, Ikizler Y, Koren G (1997) Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. Biol Neonate 71: 345–356

    Article  PubMed  CAS  Google Scholar 

  • Thisted E, Ebbesen F (1993) Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child 69: 288–291

    PubMed  CAS  Google Scholar 

  • Van Baar AI, Fleury P, Ultee CA (1989) Behaviour in the first after drug dependent pregnancy. Arch Dis Child 64: 241–245

    PubMed  Google Scholar 

  • Volpe JJ (1994) Teratogenic effects of drugs and passive addiction. In: Volpe JJ (ed) Neurology of the newborn. WB Saunders, Philadelphia, pp 811–850

    Google Scholar 

  • Wilson GS, Desmond MM, Verniaud WM (1973) Early development of infants of heroin-addicted mothers. Am J Dis Child 126: 457–462

    PubMed  CAS  Google Scholar 

  • Wisniewsky K, Dambska M, Sher JH, Qazi Q (1983) A clinical neuropathological study of the fetal alcohol syndrome. Neuropediatrics 14: 197–201

    Article  Google Scholar 

  • Zakarija M, McKenzie JM (1986) Prediction and therapy of intrauterine and late onset neonatal hyperthyroidism. J Clin Endocrinol Metab 62: 368–374

    Article  PubMed  CAS  Google Scholar 

  • Zelson C, Rubio E, Wasserman E (1971) Neonatal narcotic addiction: 10 year observation. Pediatrics 48: 178–189

    PubMed  CAS  Google Scholar 

  • Zemlin M, Bauer K, Dörner T et al. (2002) Intrauterine Therapie und kindliche ENtwicklung bei vier Schwangerschaften einer Mutter mit Sjögren-Syndrom und Anti-Ro-Autoantikörpern. Z Geburtsh Neonatol 206: 22–25

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Großhadern, Kinderklinik und Kinderpoliklinik — Neonatologie, Klinikum der Universität München, Marchioninistr. 15, 81377, München

    A. Schulze (Prof. Dr.)

Authors
  1. A. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital, Klinikum der Universität München, Lindwurmstr. 4, 80337, München

    Dietrich Reinhardt

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Schulze, A. (2007). Vorgeburtliche Schädigungen. In: Reinhardt, D. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71899-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71899-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71898-7

  • Online ISBN: 978-3-540-71899-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation